Columbia, MD, United States of America

Charles F Jewell

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Celgene Car LLC. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles F Jewell. Retrieved from https://idiyas.com/inventor/charles-f-jewell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Charles F Jewell: Innovator in Enzyme Inhibition

Introduction

Charles F Jewell is a notable inventor based in Columbia, MD (US). He has made significant contributions to the field of enzyme inhibitors through his innovative work. His expertise and dedication to research have led to advancements in pharmaceutical formulations.

Latest Patents

Charles F Jewell holds a patent for "Ligand-directed covalent modification of protein." This invention relates to enzyme inhibitors and focuses on the ligand-directed covalent modification of proteins. It includes methods for designing such modifications, pharmaceutical formulations, and methods of use.

Career Highlights

Charles is currently associated with Celgene Car LLC, where he continues to apply his knowledge and skills in the field of biochemistry and pharmaceuticals. His work has been instrumental in developing new approaches to enzyme inhibition.

Collaborations

Throughout his career, Charles has collaborated with talented individuals such as Russell Colyn Petter and Kwangho Lee. These collaborations have enriched his research and contributed to the success of his projects.

Conclusion

Charles F Jewell is a distinguished inventor whose work in enzyme inhibitors has made a significant impact in the pharmaceutical industry. His innovative approaches and collaborations continue to drive advancements in this vital field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…